Cargando…
Treatment of advanced medullary thyroid cancer
Therapy decisions in advanced medullary thyroid carcinoma should be guided by a critical appraisal of the natural disease course (slowly progressive vs. aggressive) and benefits and side effects of therapy. Therapy goals should be distinguished between curative and palliative. Local treatments are m...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3599721/ https://www.ncbi.nlm.nih.gov/pubmed/23514632 http://dx.doi.org/10.1186/1756-6614-6-S1-S7 |
| _version_ | 1782263084195250176 |
|---|---|
| author | Smit, Johannes |
| author_facet | Smit, Johannes |
| author_sort | Smit, Johannes |
| collection | PubMed |
| description | Therapy decisions in advanced medullary thyroid carcinoma should be guided by a critical appraisal of the natural disease course (slowly progressive vs. aggressive) and benefits and side effects of therapy. Therapy goals should be distinguished between curative and palliative. Local treatments are mainly palliative and may add to quality of life. The advent of novel systemic therapies opens promising perspectives but its place in the therapeutic arsenal must be further determined. |
| format | Online Article Text |
| id | pubmed-3599721 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2013 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-35997212013-03-25 Treatment of advanced medullary thyroid cancer Smit, Johannes Thyroid Res Review Therapy decisions in advanced medullary thyroid carcinoma should be guided by a critical appraisal of the natural disease course (slowly progressive vs. aggressive) and benefits and side effects of therapy. Therapy goals should be distinguished between curative and palliative. Local treatments are mainly palliative and may add to quality of life. The advent of novel systemic therapies opens promising perspectives but its place in the therapeutic arsenal must be further determined. BioMed Central 2013-03-14 /pmc/articles/PMC3599721/ /pubmed/23514632 http://dx.doi.org/10.1186/1756-6614-6-S1-S7 Text en Copyright ©2013 Smit; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Review Smit, Johannes Treatment of advanced medullary thyroid cancer |
| title | Treatment of advanced medullary thyroid cancer |
| title_full | Treatment of advanced medullary thyroid cancer |
| title_fullStr | Treatment of advanced medullary thyroid cancer |
| title_full_unstemmed | Treatment of advanced medullary thyroid cancer |
| title_short | Treatment of advanced medullary thyroid cancer |
| title_sort | treatment of advanced medullary thyroid cancer |
| topic | Review |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3599721/ https://www.ncbi.nlm.nih.gov/pubmed/23514632 http://dx.doi.org/10.1186/1756-6614-6-S1-S7 |
| work_keys_str_mv | AT smitjohannes treatmentofadvancedmedullarythyroidcancer |